MENU

Fox Chase’s Dr. Zachary Frosch Wins NCCN Foundation Award for Rising Cancer Research Leaders

April 25, 2022

Dr. Zachary Frosch, assistant professor in the Department of Hematology/Oncology and a member of the Cancer Prevention and Control research program at Fox ChaseDr. Zachary Frosch, assistant professor in the Department of Hematology/Oncology and a member of the Cancer Prevention and Control research program at Fox Chase

PHILADELPHIA (April 25, 2022) — Zachary Frosch, MD, MSHP, an assistant professor in the Department of Hematology/Oncology and a member of the Cancer Prevention and Control research program at Fox Chase Cancer Center, has received a Young Investigator Award (YIA) from the National Comprehensive Cancer Network (NCCN) and the NCCN Foundation.

Frosch, who is one of seven recipients of the award, will receive up to $150,000 in funding over two years to advance research on an important issue in oncology. The NCCN Oncology Research Program managed the selection process and will provide guidance and oversight for the projects over the grant duration.

“As a former Young Investigator Award recipient myself, I know how important funding in the early years of one’s career can be. I have seen past YIA investigators go on to make meaningful and lasting contributions to the oncology community,” said Crystal S. Denlinger, MD, FACP, senior vice president and chief scientific officer at NCCN. “These awardees are chosen for being some of the best up-and-coming cancer researchers. NCCN celebrates all of the impressive investigators selected.”

Frosch’s research project is “Developing Patient-Centered Strategies to Improve Equitable Access to Cellular Therapies.” Frosch joined Fox Chase in 2021 following completion of his fellowship in hematology/oncology and a Master of Science in Health Policy Research degree at the University of Pennsylvania. During this time, he also served as an Innovation Fellow at the Penn Center for Cancer Care Innovation and an associate fellow at the Leonard Davis Institute of Health Economics.    

“As part of NCCN’s commitment to elevating cancer equity, our Young Investigator Awards include a designated category for disparities research that we are proud to support,” said Patrick Delaney, executive director of the NCCN Foundation. “NCCN Foundation Young Investigator Award recipients make important contributions to treatment innovation and advancement for people with cancer. We are eager to see where the research from this year’s recipients takes the field.”

The research from these seven recipients will be presented during the NCCN 2024 Annual Conference. Recipients of the 2020 NCCN Young Investigator Awards recently presented their research virtually during the NCCN 2022 Annual Conference. The NCCN Foundation has awarded 66 researchers more than $9.7 million since 2011 through the YIA program.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

 

For more information, call 888-369-2427

Connect with Fox Chase